Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, March 25, 2026.
Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Crossroads (-60) - HALO is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid HALO?
MarketClub looks at technical strength and momentum to determine if the timing is right for HALO.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for HALO
The long-term trend has been UP since Feb 3rd, 2026 at 75.59
The intermediate-term trend has been DOWN since Feb 23rd, 2026 at 70.56
The short-term trend has been DOWN since Mar 24th, 2026 at 62.51
Smart Scan Analysis for HALO
Based on our trend formula, HALO is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 62.780 | 63.620 | 62.690 | 63.225 | +1.185 |
| Prev. Close | Volume | Bid | Ask | Time |
| 62.040 | 724213 | 2026-03-25 15:59:42 |
| Year High | 21.48 | Year High Date | 2018-03-20 |
| Year Low | 14.33 | Year Low Date | 2018-10-24 |
| 52wk High | 82.22 | 52wk High Date | 2026-02-09 |
| 52wk Low | 47.5 | 52wk Low Date | 2025-05-14 |
| Year End Close | 6.71 | Average Volume | 1,665,432 |
| Shares Outstanding | 118,017 | Short Interest | 7,187,220 |
| % Institutional | 64.2 | Assets | 252,532,300M |
| Liabilities | 247,650,900M | P/E Ratio | 24.2344 |
| Beta | 1.71 | Volatility | 61.89 |